Plain-English translation of NCT05541744 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Researchers are studying the genetic makeup of lung tumors to better understand what makes each patient's cancer unique. By analyzing tumor tissue that's already been removed during diagnosis or treatment, they hope to identify specific genetic patterns that could help doctors choose the most effective treatments for individual patients.
Currently, doctors treat lung cancer somewhat the same way for most patients, but every tumor is different genetically. This study exists to create a better map of those genetic differences so that treatment can be tailored to each person's specific cancer type.
You likely qualify if…
You likely don't qualify if…
Your participation is mainly observational — researchers will use tumor tissue samples that have already been collected from you during your diagnosis or treatment. They will perform genetic testing and analyze specific proteins in your tumor to identify mutations and other characteristics. There are no new invasive procedures; the study uses existing pathology samples to create a genetic profile of your cancer.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Taiwan
Enrollment target
~120 participants
Started
August 2023
Primary completion
July 2026
Age range
20 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yu-Hung Chen, M.D.
Buddhist Tzu Chi General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.